title: Progesterone responses to intravenous and intrauterine infusions of prostaglandin F2alpha in mares.
abstract: The hypotheses were tested that prostaglandin F2alpha (PGF) travels from the uterus to the ovaries via a systemic route in mares, as opposed to a local route in ruminants, and that one pulse of PGF produces only partial luteolysis. Intravenous (i.v.) and intrauterine (i.u.) infusions of PGF were performed 8 days after ovulation at a constant rate for 2 h. Plasma concentrations of PGF were assessed by assay of 13,14-dihydro-15-keto-PGF2alpha (PGFM). Total doses administered were as follows: 0, 0.05, 0.1, 0.5 and 1.0 mg, i.v., PGF and 0 and 0.5 mg, i.u., PGF (n=4 mares per group). In addition, PGFM concentrations were determined for natural pulses from samples collected each hour during luteolysis (n=5). Progesterone was similarly reduced by 4 days after treatment in the 0.5 mg i.v., 0.5 mg i.u. and 0.0 mg i.u. groups. The area under the PGFM curve in the 0.1 mg i.v. group was similar to the area for natural PGFM pulses. Progesterone decreased to a similar concentration by 12 h in the 0.1, 0.5 and 1.0 mg i.v. groups, but thereafter was greater (P<0.05) in the 0.1 mg i.v. group. Progesterone concentrations reached <2 ng mL(-1) 6 days after treatment in the 0.05 and 0.1 mg i.v. groups and 2 days after treatment in the 0.5 and 1.0 mg i.v. groups. The results support the hypotheses of a systemic uteroluteal route for PGF transfer and that one pulse produces only partial luteolysis in mares.
authors.affiliation: Eutheria Foundation, Cross Plains, WI 53528, USA. ginther@svm.vetmed.wisc.edu
authors.forename: O J
authors.initials: OJ
authors.lastname: Ginther
authors.forename: M A R
authors.initials: MA
authors.lastname: Siddiqui
authors.forename: M A
authors.initials: MA
authors.lastname: Beg
mesh_terms: D000818:Animals; D003338:Corpus Luteum / Q000378:metabolism; D015237:Dinoprost / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006736:Horses / Q000378:metabolism*; D007262:Infusions, Intravenous; D003341:Luteolysis / Q000187:drug effects / Q000502:physiology; D011374:Progesterone / Q000097:blood*; D014599:Uterus / Q000378:metabolism
chemical_list: C008228:15-keto-13,14-dihydroprostaglandin F2alpha; D011374:Progesterone; D015237:Dinoprost